Novo Nordisk’s semaglutide fails to slow Alzheimer’s progression The company started the trials after retrospective data indicated the drug might have an impact on the disease

https://www.statnews.com/2025/11/24/novo-nordisk-semaglutide-wegovy-ozempic-alzheimers-trial-failure/ By Andrew Joseph and Elaine ChenNov. 24, 2025